v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities    
Net Loss $ (5,178,000) $ (12,257,000)
Adjustments to reconcile net loss to cash used in operating activities:    
Depreciation and amortization 566,000 101,000
Stock-based compensation 48,000 1,338,000
Decrease in the carrying amount of right-of-use-assets 363,000 781,000
(Gain) on lease termination (10,000) 0
Amortization of debt issuance costs 0 9,000
Accretion of final payment on term loans 0 32,000
Changes in operating assets and liabilities:    
Account receivable 195,000 945,000
Prepaid expenses and other current assets (880,000) (1,078,000)
Deposits 62,000 16,000
Other payable 314,000 535,000
Accounts payable (622,000) 961,000
Accrued expenses (112,000) 1,322,000
Research and development contract liability (5,335,000) (85,000)
Operating lease liability (353,000) (792,000)
Net cash used in operating activities (10,942,000) (8,172,000)
Cash flows from investing activities    
Purchases of property and equipment (121,000) (150,000)
Net cash used in investing activities (121,000) (150,000)
Cash flows from financing activities    
Proceeds from ATM offering, net of sales agent commissions and fees 306,000 0
Repayment of term loans 0 (1,000,000)
Net cash provided by (used in) financing activities 306,000 (1,000,000)
Net decrease in cash, cash equivalents, and restricted cash (10,757,000) (9,322,000)
Cash, cash equivalents, and restricted cash at beginning of period 27,290,000 22,611,000
Cash, cash equivalents, and restricted cash at end of period 16,533,000 13,289,000
Supplemental disclosures of non-cash investing and financing activities:    
Cash paid for interest $ 0 $ 90,000